The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next...
During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President...
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed how...
At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay...
The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR,...
Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents...
At the AACR Annual Meeting 2026, we conducted "Bite-sized Research" interviews with attendees for morsels of knowledge about their...
Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer...
At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to...